Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olopatadine Hydrochloride Granules

Approval Number

国药准字H20234298

Company北京四环科宝制药股份有限公司

Registration Date

October 18, 2023

Drug Information

Generic Name

盐酸奥洛他定颗粒

Dosage Form

颗粒剂

Strength

2.5mg

Drug Type

化学药品

Registration Date

October 18, 2023

Company Information

Applicant Company

Company Name北京四环科宝制药股份有限公司

Company Address

北京市丰台区科技园区海鹰路11号[园区]

Manufacturing Company

Company Name北京四环科宝制药股份有限公司

Company Address

北京市大兴区中关村科技园区大兴生物医药基地祥瑞街5号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy